Ebola hemorrhagic fever outbreaks: strategies for effective epidemic management, containment and control.
Matua GA, Van der Wal DM, Locsin RC.
Braz J Infect Dis. 2015 May-Jun;19(3):308-13. doi: 10.1016/j.bjid.2015.02.004. Epub 2015 Apr 17.
Ebola haemorrhagic fever virus: pathogenesis, immune responses, potential prevention.
Marcinkiewicz J, Bryniarski K, Nazimek K.
Folia Med Cracov. 2014;54(3):39-48.
Ebola hemorrhagic Fever.
Burnett MW.
J Spec Oper Med. 2014 Fall;14(3):93-94. doi: 10.55460/JBMR-T6LY.
Ebola hemorrhagic fever: genetic biomarkers and vaccine development.
Oliphant E.
Genet Test Mol Biomarkers. 2014 Nov;18(11):715-6. doi: 10.1089/gtmb.2014.1560. Epub 2014 Oct 23.
Ebola virus disease: A narrative review.
Letafati A, Salahi Ardekani O, Karami H, Soleimani M.
Microb Pathog. 2023 Aug;181:106213. doi: 10.1016/j.micpath.2023.106213. Epub 2023 Jun 23.
Ebola hemorrhagic fever in the era of bioterrorism.
Polesky A, Bhatia G.
Semin Respir Infect. 2003 Sep;18(3):206-15.
Ebola hemorrhagic fever: current outbreak and progress in finding a cure.
Saeidnia S, Abdollahi M.
Daru. 2014 Nov 12;22(1):70. doi: 10.1186/s40199-014-0070-9.
General introduction into the Ebola virus biology and disease.
Zawilińska B, Kosz-Vnenchak M.
Folia Med Cracov. 2014;54(3):57-65.
Pharmacotherapy of Ebola hemorrhagic fever: a brief review of current status and future perspectives.
Olszanecki R, Gawlik G.
Folia Med Cracov. 2014;54(3):67-77.
Ebola hemorrhagic fever (EHF): mechanism of transmission and pathogenicity.
Mwanatambwe M, Yamada N, Arai S, Shimizu-Suganuma M, Shichinohe K, Asano G.
J Nippon Med Sch. 2001 Oct;68(5):370-5. doi: 10.1272/jnms.68.370.
